本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Dianthus Therapeutics Inc.

21.85
+0.0000
成交量:12.88万
成交额:279.37万
市值:7.02亿
市盈率:-8.57
高:22.05
开:21.60
低:21.28
收:21.85
数据加载中...
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/26

SEC问询函

Form CORRESP - Correspondence
2024/03/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

SEC问询函

Form CORRESP - Correspondence
2024/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/22

重要事件披露

Form 8-K - Current report